Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Sr ...

A newly identified long noncoding RNA (lncRNA), named lnc2300, plays a protective role in ovarian granulosa cells but is ...

While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as "chemo brain." These effects ...

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

Volume 33 of SLAS Discovery features one review, three original research articles and one entry in the upcoming Special Issue on ...

Using quantitative proteomics, the authors uncover that ZMAT3 knockout leads to upregulation of HKDC1, a gene linked to mitochondrial respiration, and that ZMAT3 suppresses HKDC1 expression by ...

John Mascarenhas, MD, discusses the rationale, mechanism, and design of the phase 1 INCA33989-101 and -102 trials investigating a CAL-R–targeted antibody for patients with essential thrombocythemia.

To his point, a 2016 study found that after women with central obesity took a green tea extract supplement for 12 weeks, they exhibited "significant weight loss, reduced waist circumference, and a ...

Major depressive disorder affects hundreds of millions worldwide, but a key to understanding its origins may lie in the brain ...

Arkay Beverages, the pioneer in zero-proof spirits, is proud to announce that its entire range — including whisky, vodka, rum ...

CAR-T cells, which are genetically programmed to specifically recognize and kill target cells, have altered the therapeutic ...

Waldenstrom Macroglobulinemia sees growing innovation as next-gen BTK inhibitors and novel therapies aim to overcome resistance and reshape treatment pathways. BTK inhibitors laid the groundwork, but ...